Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04700241
Other study ID # METC 20-0.78
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 21, 2021
Est. completion date May 5, 2021

Study information

Verified date April 2021
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Disturbances in brain insulin-sensitivity are not only observed in abdominal obesity and type 2 diabetes mellitus (T2D), but also during brain aging and in dementia. Inorganic nitrate may improve brain insulin-sensitivity, which can be quantified by measuring the gray-matter cerebral blood flow (CBF) response to intranasally administered insulin, through beneficial effects on brain vascular function. Therefore, we now hypothesize that inorganic nitrate, which can be found in several vegetables such as beetroot, improves brain insulin-sensitivity, as assessed by the gray-matter CBF response to intranasally administered insulin, in abdominally obese men.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date May 5, 2021
Est. primary completion date May 5, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Men; - Aged between 18 - 60 years; - Waist circumference > 102 cm (abdominally obese); - Fasting plasma glucose = 7.0 mmol/L; - Fasting serum total cholesterol = 8.0 mmol/L; - Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg; - Stable body weight (weight gain or loss < 3 kg in the past three months); - Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study; - Willingness not to use antibacterial mouth wash or toothpaste, chewing-gum and tongue-scraping a week before the study; - No difficult venipuncture as evidenced during the screening visit. Exclusion Criteria: - Women; - Left-handedness; - Current smoker, or smoking cessation < 12 months; - Diabetic patients; - Familial hypercholesterolemia; - Abuse of drugs; - More than 3 alcoholic consumptions per day; - Use of products or dietary supplements known to interfere with the main outcomes as judged by the principal investigators; - Use medication to treat blood pressure, lipid or glucose metabolism; - Pharmacological treatment advised based on the Dutch general practitioners' association (NHG) for cardiovascular risk management; - Use of an investigational product within another biomedical intervention trial within the previous 1-month; - Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis; - Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident; - Specific contra-indications for MRI imaging, including pacemakers, surgical clips/material in body, metal splinters in eye, claustrophobia, or tattoos in the facial area, such as permanent make-up.

Study Design


Intervention

Dietary Supplement:
Potassium nitrate
Acute intervention (5.5 hours)
Placebo
Acute intervention (5.5 hours)

Locations

Country Name City State
Netherlands Maastricht University Medical Center Maastricht Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Brain insulin sensitivity MRI arterial spin labeling, cerebral blood flow measurements before and after a nasal insulin spray Change from placebo intervention at 2 hours after supplement intake
Secondary Brain vascular function MRI arterial spin labeling, cerebral blood flow measurements Change from placebo intervention at 2 hours after supplement intake
Secondary Vascular function markers Flow-mediated vasodilation (FMD) of the brachial and femoral artery Change from fasting at 4 hours after supplement intake
Secondary Cold pressure test Carotid artery response to cold pressure test Change from placebo at 4 hours after supplement intake
Secondary Cardiometabolic risk markers (1) Plasma markers for low-grade systemic inflammation (CRP) Change from placebo at 4 hours after supplement intake
Secondary Cardiometabolic risk markers (2) Plasma marker for endothelial dysfunction (NOx) Change from placebo at 4 hours after supplement intake
Secondary Cardiometabolic risk markers (3) Office blood pressure Change from placebo at 4 hours after supplement intake
Secondary Cardiometabolic risk markers (4) Plasma brain derived neurotrophic factor (BDNF) During the 5.5 hours following supplement intake
Secondary Postprandial metabolism (1) Serum lipid metabolism During the 5.5 hours following supplement intake
Secondary Postprandial metabolism (2) Plasma glucose metabolism During the 5.5 hours following supplement intake
See also
  Status Clinical Trial Phase
Completed NCT03866343 - Restriction of Dietary AGEs to Prevent Diabetes in Overweight Individuals N/A
Completed NCT02065271 - Herbal Preparation and Glucose Homeostasis N/A
Completed NCT01945970 - Effect of Black Tea on Vascular Function N/A
Completed NCT01495325 - Effect of Woodsmoke on Vascular Function N/A
Terminated NCT04239482 - Nutritional Supplementation and Insulin Sensitivity N/A
Completed NCT02273323 - Flow Mediated Dilation in Response to Black Tea N/A
Completed NCT04550026 - Cardiovascular Effects of Heated Tobacco Products (HTP) N/A
Completed NCT03849300 - Impacts of Aquatic vs Land Walking on Vascular Health and Exercise Tolerance in Patients With Peripheral Artery Disease N/A
Terminated NCT04770155 - Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1 Early Phase 1
Active, not recruiting NCT01312168 - Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment N/A
Not yet recruiting NCT06440512 - The Effect of Chocolate on Vascular Function of Endurance Runners N/A
Not yet recruiting NCT06229873 - Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure N/A
Recruiting NCT05468255 - The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults N/A
Completed NCT01805063 - Effect of Fire Suppression and Emergency Duties on Vascular Function
Completed NCT02328339 - Tea and Forearm Blood Flow N/A
Completed NCT01575041 - The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function N/A
Completed NCT03324256 - Energy Drinks and Vascular Function N/A
Completed NCT04175457 - The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis N/A
Completed NCT01053026 - Evaluation of Effects of Exercise Training and ARB in DM Patients N/A
Completed NCT03625596 - Nutritional Supplements and Nitric Oxide Bioactivity N/A